NovaBay Pharmaceuticals shares are trading lower after the company priced a public offering of 3.2M shares and warrants at $1.10 per share.
Portfolio Pulse from Benzinga Newsdesk
NovaBay Pharmaceuticals shares are trading lower after the company priced a public offering of 3.2M shares and warrants at $1.10 per share.
July 26, 2024 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NovaBay Pharmaceuticals shares are trading lower after the company priced a public offering of 3.2M shares and warrants at $1.10 per share.
The pricing of the public offering at $1.10 per share is likely perceived as dilutive by investors, leading to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100